Navigation Links
Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings

PARSIPPANY, N.J., April 20, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the Company intends to release its first quarter 2012 financial results on Monday, April 30, 2012 prior to the open of the U.S. financial markets.  The Company will also host a conference call and webcast at 8:30 a.m. Eastern Time on April 30, 2012 to discuss its financial results and provide an update on the Company's outlook for 2012.  The dial-in number to access the call is US/Canada (877) 251-7980, International (706) 643-1573, and the Conference ID is 73123257.

A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Time on May 14, 2012.  The replay may be accessed by dialing (855) 859-2056 and entering pass code 73123257.  From international locations, the replay may be accessed by dialing (404) 537-3406 and entering the same pass code.  To access the webcast, go to Watson's Investor Relations Web site at  A replay of the webcast will also be available.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leading integrated global pharmaceutical company. The Company is engaged in the development and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at

(Logo: )CONTACTS:Investors:Patty Eisenhaur (862) 261-8141Media:Charlie Mayr(862) 261-8030


SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Taconic IPAs Annette Watson to present at PCPCC meeting
2. Watson Launches Generic FORTAMET(R)
3. Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim®
4. Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit
5. Watson Partners With March of Dimes to Help Fight Preterm Birth
6. Watson Confirms NIASPAN(R) Patent Challenge
7. Watson Confirms BYSTOLIC(R) Patent Challenge
8. Watson Launches Generic PROMETRIUM(R)
9. Watson to Present at the Barclays Capital 2012 Global Healthcare Conference
10. Watson Receives Complete Response Letter from FDA for Progesterone Vaginal Gel 8%
11. Watson to Present at the 2012 RBC Capital Markets Healthcare Conference
Post Your Comments:
(Date:11/30/2015)... --  Royal Philips  (NYSE: PHG ; AEX: ... a fully integrated, consultative approach to enhance radiology ... management approaches that combine imaging systems, services, informatics ... delivery and reduce costs. Making its debut at ... Annual Meeting (RSNA) in Chicago ...
(Date:11/30/2015)... DULLES, Va. , Nov. 30, 2015  IBA ... the manufacture and distribution of radiopharmaceuticals, announced that as ... Zevacor Pharma, Inc. (Zevacor Pharma). The decision to rebrand ... of the firm as well as its close relationship ... owned by Illinois Health and Science (IHS). ...
(Date:11/30/2015)... BOCA RATON, Fla. , Nov. 30, ... of Public Research (the Institute) announced today that ... , a medical device start-up company with technology developed ... creation based on publicly-funded research, and bridges early funding ... -based universities and research institutions. ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... HemoTreat™ ... list of its hemorrhoid ointment to its website. , “Our goal is simple:” ... suffering from hemorrhoids. Adding the comparison chart and ingredient list allows our customers ...
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood sugar ... and adults, according to a new study by researchers at the School of Public ... and Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in Public ...
(Date:11/30/2015)... ... November 30, 2015 , ... The recently published ... Data System (NPDS) reveals that in 2014, someone called a poison center about ... million of which were human exposure cases. , The American Association of Poison ...
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag Specialties, Inc. (BSI) ... for the Nutraceutical Specialties products into oral solid dosage in the over the ... “We are pleased to announce our expanded distribution agreement with ASI.” said Steve ...
(Date:11/30/2015)... ... 30, 2015 , ... Medicalis, a leading developer of enterprise-scale ... America (RSNA) annual meeting, being held November 29 – December 3, 2015, that ... the company has completed installations for Integrated Delivery Network (IDN) customers such as ...
Breaking Medicine News(10 mins):